is_manufactured_by has function has role has component vaccinated in route immunizes against disease immunizes recipient immunizes against pathogen has drug brand name Human papillomavirus infectious disease Human papillomavirus Homo sapiens FDA licensed vaccine role intramuscular route USA licensed human vaccine preventive vaccine function prophylactic vaccine protein of pathogen organism as vaccine component recombinant vector vaccine subunit vaccine multivalent vaccine subunit vaccine role recombinant vector vaccine role human papillomavirus vaccine Canada licensed human vaccine Canada licensed vaccine role Gardasil 9 vaccine https://www.cancer.org/latest-news/fda-approves-gardasil-9-hpv-vaccine.html https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm426445.htm Omar Tibi VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=5546 http://purl.bioontology.org/ontology/RXNORM/1597095 vaccine 5546 Indicated in girls and women 9 through 45 years of age for the prevention of the following diseases: - Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58. (1.1) Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.1) And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: - Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS). (1.1) - Cervical intraepithelial neoplasia (CIN) grade 1. (1.1) - Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3. (1.1) - Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3. (1.1) - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.1) GARDASIL 9 is indicated in boys and men 9 through 45 years of age for the prevention of the following diseases: - Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58. (1.2) - Genital warts (condyloma acuminata) caused by HPV types 6 and 11. (1.2) And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58: - Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3. (1.2) Khadeejah Khan Oliver He https://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM426457.pdf 125508 Gardasil 9 Kallan Roan L1 protein, Human papillomavirus type 6 Vaccine L1 protein, Human papillomavirus type 11 Vaccine L1 protein, Human papillomavirus type 18 Vaccine L1 protein, Human papillomavirus type 16 Vaccine L1 protein, Human papillomavirus type 31 Vaccine L1 protein, Human papillomavirus type 33 Vaccine L1 protein, Human papillomavirus type 45 Vaccine L1 protein, Human papillomavirus type 52 Vaccine L1 protein, Human papillomavirus type 58 Vaccine vaccine multivalent role licensed human papillomavirus vaccine Merck & Co., Inc. Gardasil 9